NCT02641340View on ClinicalTrials.gov

Fentanyl Sublingual Spray in Opioid Naive Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

96

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

March 31, 2016

Study Completion Date

March 31, 2016

Conditions
Pharmacology
Interventions
DRUG

Fentanyl Sublingual Spray

Fentanyl delivered at low, medium and high doses by sublingual spray (FSS)

DRUG

Fentanyl Citrate IV

Fentanyl Citrate 50 mcg, delivered intravenously

Trial Locations (1)

91105

Lotus Clinical Research, Inc., Pasadena

Sponsors
All Listed Sponsors
lead

INSYS Therapeutics Inc

INDUSTRY